Virologic Response Following a Switch to Dolutegravir-based Regimen in People Living with HIV/AIDS at a Tertiary Care Center in Nepal. (2022). Kathmandu University Medical Journal, 20(4), 438-442. https://doi.org/10.3126/kumj.v20i4.54081